JP2020526498A5 - - Google Patents

Download PDF

Info

Publication number
JP2020526498A5
JP2020526498A5 JP2019572355A JP2019572355A JP2020526498A5 JP 2020526498 A5 JP2020526498 A5 JP 2020526498A5 JP 2019572355 A JP2019572355 A JP 2019572355A JP 2019572355 A JP2019572355 A JP 2019572355A JP 2020526498 A5 JP2020526498 A5 JP 2020526498A5
Authority
JP
Japan
Prior art keywords
pyrazole
phenyl
carboxamide
piperidine
thiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019572355A
Other languages
English (en)
Japanese (ja)
Other versions
JP7167069B2 (ja
JP2020526498A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/040021 external-priority patent/WO2019006126A1/en
Publication of JP2020526498A publication Critical patent/JP2020526498A/ja
Publication of JP2020526498A5 publication Critical patent/JP2020526498A5/ja
Priority to JP2022171152A priority Critical patent/JP7379639B2/ja
Application granted granted Critical
Publication of JP7167069B2 publication Critical patent/JP7167069B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019572355A 2017-06-29 2018-06-28 キナーゼ阻害剤ならびに作製および使用のための方法 Expired - Fee Related JP7167069B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022171152A JP7379639B2 (ja) 2017-06-29 2022-10-26 キナーゼ阻害剤ならびに作製および使用のための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762526838P 2017-06-29 2017-06-29
US62/526,838 2017-06-29
PCT/US2018/040021 WO2019006126A1 (en) 2017-06-29 2018-06-28 KINASE INHIBITORS AND METHODS OF MAKING AND USING THEM

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022171152A Division JP7379639B2 (ja) 2017-06-29 2022-10-26 キナーゼ阻害剤ならびに作製および使用のための方法

Publications (3)

Publication Number Publication Date
JP2020526498A JP2020526498A (ja) 2020-08-31
JP2020526498A5 true JP2020526498A5 (cg-RX-API-DMAC7.html) 2021-08-05
JP7167069B2 JP7167069B2 (ja) 2022-11-08

Family

ID=62976284

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019572355A Expired - Fee Related JP7167069B2 (ja) 2017-06-29 2018-06-28 キナーゼ阻害剤ならびに作製および使用のための方法
JP2022171152A Active JP7379639B2 (ja) 2017-06-29 2022-10-26 キナーゼ阻害剤ならびに作製および使用のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022171152A Active JP7379639B2 (ja) 2017-06-29 2022-10-26 キナーゼ阻害剤ならびに作製および使用のための方法

Country Status (6)

Country Link
US (3) US10590121B2 (cg-RX-API-DMAC7.html)
EP (1) EP3645525A1 (cg-RX-API-DMAC7.html)
JP (2) JP7167069B2 (cg-RX-API-DMAC7.html)
CN (1) CN111032642B (cg-RX-API-DMAC7.html)
CA (1) CA3068305A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019006126A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7167069B2 (ja) * 2017-06-29 2022-11-08 ライジェル ファーマシューティカルズ, インコーポレイテッド キナーゼ阻害剤ならびに作製および使用のための方法
AU2019404576B2 (en) 2018-12-20 2025-07-17 Amgen Inc. Heteroaryl amides useful as KIF18A inhibitors
MA54550A (fr) 2018-12-20 2022-03-30 Amgen Inc Inhibiteurs de kif18a
AU2019401495B2 (en) * 2018-12-20 2025-06-26 Amgen Inc. Heteroaryl amides useful as KIF18A inhibitors
TW202100522A (zh) * 2019-03-08 2021-01-01 瑞士商赫孚孟拉羅股份公司 新穎咪唑-吡唑衍生物
WO2021018118A1 (en) * 2019-07-29 2021-02-04 Janssen Pharmaceutica Nv Compounds and methods for the targeted degradation of interleukin-1 receptor-associated kinase 1 proteins
JP7699100B2 (ja) 2019-08-02 2025-06-26 アムジエン・インコーポレーテツド Kif18a阻害剤
AU2020325115B2 (en) 2019-08-02 2026-03-12 Amgen Inc. Pyridine derivatives as KIF18A inhibitors
US20220288065A1 (en) * 2019-08-21 2022-09-15 The Scripps Research Institute Monocyclic agonists of stimulator of interferon genes sting
CN110592056A (zh) * 2019-09-19 2019-12-20 昆明理工大学 噬菌体裂解酶复合粉剂及其制备方法和应用
WO2021148420A1 (en) * 2020-01-22 2021-07-29 F. Hoffmann-La Roche Ag Novel heterocyclic compounds
AR121717A1 (es) * 2020-04-02 2022-06-29 Rigel Pharmaceuticals Inc Inhibidores de rip1k
EP4185568A1 (en) 2020-07-24 2023-05-31 The University of Rochester Inhibitors of interleukin-1 receptor-associated kinases 1 and 4
JP7886884B2 (ja) * 2021-02-07 2026-07-08 エフ. ホフマン-ラ ロシュ アーゲー 新規ヘテロアリール置換イミダゾール誘導体
US20240308980A1 (en) * 2021-03-17 2024-09-19 Merck Sharp & Dohme Llc Heteroaryl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
WO2023088435A1 (zh) * 2021-11-19 2023-05-25 成都奥睿药业有限公司 三取代吡啶衍生物的制备及作为芳香烃受体调节物的应用
ES3075943T3 (en) 2022-03-23 2026-08-10 Rigel Pharmaceuticals Inc Pyrimid-2-yl-pyrazole compounds as irak inhibitors
AU2024214768A1 (en) * 2023-01-30 2025-08-07 The Johns Hopkins University 18 f-labeled pet radiotracers for imaging macrophage colony stimulating factor 1 receptor
CN118027009B (zh) * 2024-04-15 2024-07-12 北京师范大学 一类靶向于csf1r激酶的苯基酰胺类化合物及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087240A (en) 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
US4921475A (en) 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
US4738851A (en) 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
US5163899A (en) 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
GB8804164D0 (en) 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US4882150A (en) 1988-06-03 1989-11-21 Kaufman Herbert E Drug delivery system
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US5521222A (en) 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
CA2031376A1 (en) 1989-12-04 1991-06-05 Bahram Farhadieh Single layer transdermal drug administration system
US5077033A (en) 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
DK0495421T3 (da) 1991-01-15 1996-12-09 Alcon Lab Inc Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
US5352456A (en) 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
CA2123809A1 (en) 1991-12-18 1993-06-24 Debra L. Wilfong Multilayered barrier structures
ATE132381T1 (de) 1992-01-29 1996-01-15 Voelkl Franz Ski Ballspielschläger, insbesondere tennisschläger
IL114193A (en) 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
IT1283911B1 (it) 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6197934B1 (en) 1998-05-22 2001-03-06 Collagenesis, Inc. Compound delivery using rapidly dissolving collagen film
WO2014110114A1 (en) * 2013-01-10 2014-07-17 Nimbus Iris, Inc. Irak inhibitors and uses thereof
EP3079682A4 (en) 2013-12-13 2017-08-30 Dana-Farber Cancer Institute, Inc. Methods to treat lymphoplasmacytic lymphoma
DK3286181T3 (da) 2015-04-22 2021-04-06 Rigel Pharmaceuticals Inc Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne
CA2992406A1 (en) 2015-07-15 2017-01-19 Aurigene Discovery Technologies Limited Indazole and azaindazole compounds as irak-4 inhibitors
HK1256242A1 (zh) 2015-08-04 2019-09-20 Rigel Pharmaceuticals, Inc. 吲哚化合物以及制备和使用该化合物的方法
JP7167069B2 (ja) * 2017-06-29 2022-11-08 ライジェル ファーマシューティカルズ, インコーポレイテッド キナーゼ阻害剤ならびに作製および使用のための方法

Similar Documents

Publication Publication Date Title
JP2018528181A5 (cg-RX-API-DMAC7.html)
JP7379639B2 (ja) キナーゼ阻害剤ならびに作製および使用のための方法
CN115175912B (zh) N-(4-(1-(2,6-二氟苄基)-5-((二甲基氨基)甲基)-3-(6-甲氧基-3-哒嗪基)-2,4-二氧代-1,2,3,4-四氢噻吩并[2,3-d]嘧啶-6-基)苯基)-n′-甲氧基脲的结晶溶剂化形式
ES2789331T3 (es) Inhibidores de TGF-beta
JP6994454B2 (ja) ベンズアゾール化合物ならびに該化合物の作製方法および使用方法
JP5612678B2 (ja) 抗ウイルス性複素環化合物
CN106573914B (zh) 作为激酶抑制剂的吡唑基-脲
JP6608918B2 (ja) P38キナーゼ阻害剤としてのジアリール尿素誘導体
JP2019094350A (ja) 抗癌活性及び抗増殖活性を呈する2−アミノピリミジン−6−オン及び類似体
JP7737153B2 (ja) Masp-2阻害剤および使用方法
JP7328323B2 (ja) SMARCA2/BRM ATPase阻害剤としての尿素化合物及び組成物
JP2007515432A5 (cg-RX-API-DMAC7.html)
JP2020537657A5 (cg-RX-API-DMAC7.html)
US20190389855A1 (en) Dihydroisoquinoline compound
TWI870449B (zh) 吡唑化合物,其配製物以及使用該化合物和/或配製物之方法
SI2797918T1 (en) Bromodomain inhibitors
CN105899493A (zh) 用于抑制shp2活性的1-(三嗪-3-基/哒嗪-3-基)-哌(-嗪)啶衍生物及其组合物
JP2013504604A (ja) ウイルスポリメラーゼ阻害剤としてのキナゾリノン誘導体
RU2010137635A (ru) Гетероциклические антивирусные соединения
CN105246884A (zh) 用作激酶抑制剂的脲衍生物
CN102648198A (zh) 作为s1p1/edg1受体调节剂的吡啶衍生物
JP2019537577A5 (cg-RX-API-DMAC7.html)
JP2019034970A (ja) セリン/トレオニンキナーゼ阻害剤
TW200806652A (en) N-hydroxyacrylamide compounds
JP2022546410A5 (cg-RX-API-DMAC7.html)